Legal Representation
Attorney
Richard M. LaBarge
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 31, 2015 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 31, 2015 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 13, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 12, 2015 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Feb 2, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 2, 2015 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 29, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 28, 2014 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 18, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 18, 2014 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 20, 2014 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 20, 2014 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 21, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 20, 2013 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 14, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 14, 2013 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 9, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 8, 2013 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 25, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 25, 2013 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 23, 2013 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 26, 2012 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Oct 26, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 25, 2012 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Oct 25, 2012 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 23, 2012 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 22, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2012 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Oct 22, 2012 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Oct 22, 2012 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 31, 2012 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 5, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 5, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 16, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 27, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 24, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 24, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 23, 2012 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 23, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 25, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 25, 2011 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 25, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 22, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 22, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 9, 2011 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 7, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 19, 2011 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 19, 2011 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 7, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 7, 2011 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Detailed Classifications
Class 005
Human and veterinary pharmaceuticals for use in the prevention of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; human and veterinary pharmaceuticals for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; veterinary pharmaceuticals for the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of two curved red lines that partially intersect at one point with the words "ONYX PHARMACEUTICALS" to the right of the curved lines. The color black appears in the text of the wording "ONYX PHARMACEUTICALS".
Color Claim
The color(s) red and black is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"